Close Menu

NEW YORK (360Dx) – NeoGenomics said this week it has completed its previously announced acquisition of Genoptix. NeoGenomics said that the acquisition expands its reach into the oncology space and significantly accelerates progress toward its scale and growth objectives.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.